To compare the effectiveness of Krushna Churna and Parijatak Gugulu in the treatment of Gridhrasi (Sciatica)

Not yet recruiting

• Conditions: Diseases of the nervous system. Ayurveda Condition: Gridhrasi, (2) ICD-10 Condition: G00-G99||Diseases of the nervous system. Ayurveda Condition: GRUDHRASI,

• Registration Number: CTRI/2021/06/034067
• Lead Sponsor: PDEAs College of Ayurved and Research Centre Pradhikaran Nigdi Pune

Brief Summary

Gridhrasi is one of the Vataj Nanatmaj vikar.

The location of vayu being kati pradesh , the main concern is the function of locomotion. Being epitome of all the bodily functions , it has the privilege of generating the highest number of diseases described as vataj nanatmaja vikara. Gridhrasi is one of the nanatamaj vikara of vata dosha affecting it’s main sthan that is kati pradesh according to charak samhita.

The character of gridhrasi resembles with sciatica I.e radiating pain along the course and distribution of sciatica nerve that is in buttock to outer border of foot.

The effectiveness of krushna churna with gomutra and erand tail in gridhrasi is mentioned in bhaisjaya ratnavali 26/40.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-26
• Last Update Posted: 2024-10-16

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

• 1. Patients showing classical symptoms and sign of Gridhrasi that is Padashoola (pain) ,Katishoola (pain),Stambha (stiffness) ,Toda (pricking sensation) ,Spandan (twitching) , Dehasya –Api-Pravakrata (Gait),Aruchi (Anorexia),Tandra (Drowsiness),Gaurav (Heaviness) as described in ayurvedic samhitas in Charak Chikitsasthan 28/57,58.
• Radiating pain along the course and distribution of sciatic nerve that is in buttock to outer border of foot. 2. SLR Test of patient – positive upto 60 degree. 3. Patients between the age of 25-65 years. 4. Patients from all socio-economic status.

Exclusion Criteria

• Pregnant and lactating mothers.
• Infective disorders – T.B. spine, osteomyelitis.
• Patients with paraplegia of lower limb.
• Fracture of spinal bones or in lower extremity bones 5.
• Patients having congenital anamolies with lumbosacral spine such as kyphosis, scolisis.
• Patients having any major chronic/acute; systemic/surgical pathology like malignancies.
• Patients with deep wounds penetrating till sciatic nerve.
• Patients with dislocation of hip joint, amputation above knee joint.
• 10.Patients having allergy to any content of drugs.
• High risk (above 65 years age, known cases of HTN, DM,COPD) comorbid patients suspected for covid 19.
• Suspected covid 19 patient having symptoms as per ICMR guidelines.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare efficacy of krushna churna at vynodan kal with	One month with follow up on 7th 14th 21st and 28th day
gomutra10ml & eranda tail 5 ml For 1month & parijatak gugulu 500 mg tab	One month with follow up on 7th 14th 21st and 28th day
at vyonodan kal with koshna jal for 1 month in the management of	One month with follow up on 7th 14th 21st and 28th day
Gridhrasi	One month with follow up on 7th 14th 21st and 28th day

Secondary Outcome Measures

Name	Time	Method
1. To compare and study the efficacy of krushna churna.	2. To compare and study the efficacy of Parijatak Gugulu.

Trial Locations

Locations (1)

PDEAS Ayurved Ruganalya and Sterling Multispeciality Hospital Nigdi Pradhikaran Pune; 🇮🇳 Pune, MAHARASHTRA, India

PDEAS Ayurved Ruganalya and Sterling Multispeciality Hospital Nigdi Pradhikaran Pune

🇮🇳Pune, MAHARASHTRA, India

Dr Prashant Dhondiram Chavan

Principal investigator

9421161159

prashantchavan10692@gmail.com